Journal of Chemotherapy

Yayıncı: Taylor and Francis Ltd.
Ülke: United Kingdom · Western Europe
Tür: journal
ISSN: 1120009X

19739478

Scopus 0,525 SJR

Scopus Q3 SJR Q

WoS Q3 JCR Q

WoS 2,1 JIF

Scopus 60 H-Index

Bütünleşik değerlendirme

Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.

WoS / JCR verileri 1997 ve sonrası içindir.

Scopus

Scopus · Scimago

SJR 0,525
Quartile Q3
H-Index 60
Atıf/yayın 2,07
Doküman (3y) 221
Atıf (3y) 438

Clarivate

Web of Science · JCR · 2025

JCR Q Q3
JIF 2,1
5Y JIF 1,9
JCI 0,53

WoS indeksleri

SCIE

Konu sınıflandırması

Kategoriler (SJR)

Infectious Diseases Q3
Medicine (miscellaneous) Q3
Oncology Q3
Pharmacology Q3
Pharmacology (medical) Q3

Alanlar

Medicine
Pharmacology, Toxicology and Pharmaceutics

WoS kategorileri

Oncology | Infectious Diseases | Pharmacology & Pharmacy

Yıllık quartile karşılaştırması

Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.

WoS / JCR verileri 1997 ve sonrası içindir.

Not: JCR Q, JIF, 5Y JIF, JCI ve JCI Q sütunları 1997 öncesi için boştur — bu sitede WoS/JCR verisi 1997’den başlar.
Yıl	SJR Q	JCR Q (1997+)	SJR	JIF (1997+)	5Y JIF (1997+)	JCI (1997+)	JCI Q (1997+)	H-Index
2025	Q3	Q3	0,525	2,1	1,9	0,53	Q3	60
2024	Q3	Q3	0,479	1,8	1,8	0,49	Q3	59
2023	Q3	Q3	0,439	1,9	2	0,5	Q3	59
2022	Q3	Q4	0,388	1,8	2	0,44	Q3	59
2021	Q3	Q4	0,429	2,4	2,1	0,46	Q3	59
2020	Q3	Q4	0,515	1,7	1,8	0,48	Q3	59
2019	Q2	Q4	0,476	1,7	1,4	0,47	Q3	59
2018	—	Q4	—	1,6	1,5	0,46	Q3	—
2017	Q2	Q4	0,483	1,5	1,5	0,4	Q4	59
2016	Q2	Q4	0,521	1,6	1,4	—	—	59
2015	Q2	Q4	0,512	1,3	1,1	—	—	59
2014	Q2	Q3	0,518	1,6	1,2	—	—	59
2013	Q3	Q4	0,347	1,1	1	—	—	59
2012	Q2	Q4	0,397	0,8	1	—	—	59
2011	Q2	Q4	0,462	1,1	1	—	—	59
2010	Q2	Q4	0,464	1,1	1	—	—	59
2009	—	Q4	—	1,2	1,1	—	—	—
2008	—	Q4	—	0,8	1,1	—	—	—
2007	—	Q4	—	0,9	1,1	—	—	—
2006	—	Q3	—	1,4	—	—	—	—
2005	—	Q3	—	1,1	—	—	—	—
2004	—	Q3	—	1,1	—	—	—	—
2003	—	Q3	—	1,1	—	—	—	—
2002	—	Q3	—	0,8	—	—	—	—
2001	—	Q3	—	1,3	—	—	—	—
2000	—	Q3	—	0,9	—	—	—	—
1999	—	Q3	—	0,8	—	—	—	—
1998	—	Q3	—	0,7	—	—	—	—
1997	—	Q4	—	0,3	—	—	—	—

JCR kategori quartile geçmişi

Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.

WoS / JCR verileri 1997 ve sonrası içindir.

Not: Bu tablo 1997+ Clarivate kategori quartile kayıtlarını gösterir.
Yıl	Kategori	Edition	JCR Q (1997+)	JCI Q (1997+)	Sıra
2025	INFECTIOUS DISEASES	SCIE	Q3	Q3	95/141
2025	ONCOLOGY	SCIE	Q3	Q3	236/333
2025	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	240/356
2024	INFECTIOUS DISEASES	SCIE	Q3	Q3	95/137
2024	ONCOLOGY	SCIE	Q4	Q3	253/328
2024	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	244/352
2023	INFECTIOUS DISEASES	SCIE	Q3	Q3	90/132
2023	ONCOLOGY	SCIE	Q3	Q3	234/322
2023	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	231/354
2022	INFECTIOUS DISEASES	SCIE	Q4	Q3	84/96
2022	ONCOLOGY	SCIE	Q4	Q3	220/241
2022	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	231/278
2021	INFECTIOUS DISEASES	SCIE	Q4	Q3	78/95
2021	ONCOLOGY	SCIE	Q4	Q3	210/245
2021	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	213/279
2020	INFECTIOUS DISEASES	SCIE	Q4	Q3	83/93
2020	ONCOLOGY	SCIE	Q4	Q3	227/242
2020	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	237/276
2019	INFECTIOUS DISEASES	SCIE	Q4	Q3	78/92
2019	ONCOLOGY	SCIE	Q4	Q3	222/244
2019	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	225/271
2018	INFECTIOUS DISEASES	SCIE	Q4	Q3	73/89
2018	ONCOLOGY	SCIE	Q4	Q3	207/230
2018	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	210/267
2017	INFECTIOUS DISEASES	SCIE	Q4	Q4	74/88
2017	ONCOLOGY	SCIE	Q4	Q4	203/223
2017	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q4	213/261
2016	INFECTIOUS DISEASES	SCIE	Q4	—	68/84
2016	ONCOLOGY	SCIE	Q4	—	182/217
2016	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	196/257
2015	INFECTIOUS DISEASES	SCIE	Q4	—	67/83
2015	ONCOLOGY	SCIE	Q4	—	185/213
2015	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	203/255
2014	INFECTIOUS DISEASES	SCIE	Q4	—	60/78
2014	ONCOLOGY	SCIE	Q4	—	169/211
2014	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	175/255
2013	ONCOLOGY	SCIE	Q4	—	179/203
2013	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	204/256
2012	ONCOLOGY	SCIE	Q4	—	182/197
2012	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	219/261
2011	ONCOLOGY	SCIE	Q4	—	163/196
2011	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	203/261
2010	ONCOLOGY	SCIE	Q4	—	152/185
2010	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	193/252
2009	ONCOLOGY	SCIE	Q4	—	136/166
2009	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	184/237
2008	ONCOLOGY	SCIE	Q4	—	137/143
2008	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	187/219
2007	ONCOLOGY	SCIE	Q4	—	124/132
2007	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	170/205
2006	ONCOLOGY	SCIE	Q4	—	109/127
2006	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	137/199
2005	ONCOLOGY	SCIE	Q4	—	106/123
2005	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	143/193
2004	ONCOLOGY	SCIE	Q4	—	102/123
2004	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	134/187
2003	ONCOLOGY	SCIE	Q4	—	101/120
2003	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	132/185
2002	ONCOLOGY	SCIE	Q4	—	97/114
2002	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	139/188
2001	ONCOLOGY	SCIE	Q3	—	79/107
2001	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	106/186
2000	ONCOLOGY	SCIE	Q4	—	83/103
2000	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	121/181
1999	ONCOLOGY	SCIE	Q4	—	83/105
1999	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	121/175
1998	ONCOLOGY	SCIE	Q4	—	82/104
1998	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	123/178
1997	ONCOLOGY	SCIE	Q4	—	92/102
1997	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	148/157